ARTICLE | Company News
Collagen Corp. biomaterial/skin/wound news
October 16, 1995 7:00 AM UTC
CGEN (Palo Alto) will take a non-recurring charge of $14.8 million ($1.50 per share) in its first quarter ended Sept. 30 for purchased in-process R&D relating to the previously announced acquisition o...